Market Tracker

11/28 4:25pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

36.90
Real-Time Quote
 +0.09 / +0.24%
Today’s Change
27.51
Today|||52-Week Range
39.95
+26.37%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close36.81
Today’s open36.80
Day’s range36.43 - 37.23
Volume138,310
Average volume (3 months)728,499
Market cap$1.5B
Dividend yield--
Data as of 11:35am ET, 11/28/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)+14.66%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio66.1
Price/Sales3.49
Price/Book3.42

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.66+1.46%
HZNPHorizon Pharma PLC-0.28-2.17%
GWPHGW Pharmaceuticals P...-1.30-1.62%
NBIXNeurocrine Bioscienc...+0.43+2.16%
Data as of 11:50am ET, 11/28/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)$0.06
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts